Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

被引：33

作者：

Ridker, PM ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Leducq Ctr Cardiovasc Res, Boston, MA 02115 USA

来源：

EUROPEAN HEART JOURNAL | 2001年 / 22卷 / 23期

关键词：

D O I：

10.1053/euhj.2001.2990

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2135 / 2137

页数：3

共 16 条

[1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[2] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].

Danesh, J ;

Whincup, P ;

Walker, M ;

Lennon, L ;

Thomson, A ;

Appleby, P ;

Gallimore, JR ;

Pepys, MB .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204

[3] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[4] Using cost-effectiveness analysis to target cholesterol reduction [J].

Garber, AM .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (10) :833-835

[5] Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [J].

Gotto, AM ;

Whitney, E ;

Stein, EA ;

Shapiro, DR ;

Clearfield, M ;

Weis, S ;

Jou, JY ;

Langendörfer, A ;

Beere, A ;

Watson, DJ ;

Downs, JR ;

de Cani, JS .

CIRCULATION, 2000, 101 (05) :477-484

[6] Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease [J].

Horne, BD ;

Muhlestein, JB ;

Carlquist, JF ;

Bair, TL ;

Madsen, TE ;

Hart, NI ;

Anderson, JL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1774-1780

[7] C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men -: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 [J].

Koenig, W ;

Sund, M ;

Fröhlich, M ;

Fischer, HG ;

Löwel, H ;

Döring, A ;

Hutchinson, WL ;

Pepys, MB .

CIRCULATION, 1999, 99 (02) :237-242

[8]

Ridker PM, 2001, CIRCULATION, V103, P1191

[9] Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, MA ;

Sacks, FM ;

Moye, LA ;

Goldman, S ;

Flaker, GC ;

Braunwald, E .

CIRCULATION, 1998, 98 (09) :839-844

[10] Evaluating novel cardiovascular risk factors: Can we better predict heart attacks? [J].

Ridker, PM .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (11) :933-937

← 1 2 →